PHIO PHARMACEUTICALS CORP. Assets, Fair Value Disclosure
PHIO PHARMACEUTICALS CORP. (PHIO) had Assets, Fair Value Disclosure of $16.05 million as of 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2013-08-14
- 2013-06-30: Assets, Fair Value Disclosure $16.05M.
- 2013-03-31: Assets, Fair Value Disclosure $10.05M.
- 2012-12-31: Assets, Fair Value Disclosure $53.00K.
- 2012-09-30: Assets, Fair Value Disclosure $53.00K.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2013-06-30 | $16.05M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $10.05M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $53.00K 10-Q · filed 2013-08-14 |
| 2012-09-30 | $53.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $53.00K 10-Q · filed 2012-08-14 |
| 2011-12-31 | $53.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |